Current status of the prevalence, diagnosis, and treatment of hepatitis C in patients undergoing hemodialysis
10.3760/cma.j.issn.1007-3418.2017.03.016
- VernacularTitle: 血液透析患者丙型肝炎流行、诊断及治疗的现况概述
- Author:
Guoli YANG
1
;
Xuezhong LEI
Author Information
1. Center for Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610000, China
- Publication Type:Review
- Keywords:
Hepatitis C Virus;
Diagnosis;
Therapeutics;
Hemodialysis
- From:
Chinese Journal of Hepatology
2017;25(3):233-236
- CountryChina
- Language:Chinese
-
Abstract:
Patients undergoing hemodialysis have a higher rate of hepatitis C virus infection than the general population, and due to various factors including hemodialysis and immunosuppression, it is difficult to make a diagnosis. The appearance of direct-acting antiviral agents greatly promotes the treatment of hepatitis C, but there are still no adequate data on their effect and safety in patients undergoing hemodialysis. This article discusses the prevalence, diagnosis, and treatment of hepatitis C in patients undergoing hemodialysis.
